- (PLX AI) - Biomerieux Q1 sales EUR 837 million.
- • Q1 organic decline 4.5% at constant FX
- • FY outlook unchanged
- • Anticipated headwinds in Immunoassays with lower COVID-related assays demand
Realtime | Geld | Brief | Zeit |
---|---|---|---|
96,98 | 97,66 | 04.02. | |
97,06 | 97,56 | 03.02. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
17.01. | InDevR raises $9 Million in Series B Financing and Partners with bioMérieux | ||
14.09.22 | Research and Markets: EMEA Gastrointestinal Testing Panels Market Report 2022: Featuring Key Players BD, bioMerieux, DiaSorin, Quidel & Others - ResearchAndMarkets.com | The "Gastrointestinal Testing Panels Market Europe and Middle East Africa Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's... ► Artikel lesen | |
31.08.22 | Biomerieux H1 Revenue Just Below Expectations; Guidance Slightly Improved | (PLX AI) - Biomerieux half year revenue EUR 1,658 million vs. estimate EUR 1,707 million.• Half year net income EUR 228 million• Outlook FY revenue growth -6 to -3%, up from -7% to -3% previously ► Artikel lesen | |
16.08.22 | Research and Markets: Global Lateral Flow Assay Market Report to 2029 - Featuring Abbott Laboratories, Danaher and bioMerieux Among Others - ResearchAndMarkets.com | The "Lateral Flow Assay Market Analysis by Application (Drug Development Quality Testing, Testing), by Product (Lateral Flow Readers, Kits Reagents by Technique (Competitive Assays, Sandwich Assays)... ► Artikel lesen |